Correspondence| Volume 20, ISSUE 12, P1335-1336, December 1985

Naloxone and tardive dyskinesia

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bluym I.
        • Munitz H.
        • Shalev A.
        • Roberts E.
        Naloxone may be beneficial in the treatment of tardive dyskinesia.
        Clin Neuropharmacol. 1984; 7: 265-267
        • Brambilla F.
        • Facchinetti F.
        • Petraglia F.
        • et al.
        Secretion patterns of endogenous opioids in chronic schizophrenia.
        Am J Psychiatry. 1984; 141: 1183-1189
        • Cuello A.C.
        Central distribution of opioid peptides.
        Br Med Bull. 1983; 39: 11-16
        • Gillman M.A.
        • Sandyk R.
        Evidence for underactivity of the opioid system in neuroleptic-induced akathisia.
        Psychiatry Res. 1984; 13: 187
        • Hornykiewicz O.
        Brain catecholamines in schizophrenia: A good case for noradrenaline.
        Nature. 1982; 299: 484-486
        • Sandyk R.
        • Gillman M.A.
        Noradrenaline and tardive dyskinesia.
        Br J Psychiatry. 1984; 145: 217